You will receive alerts when there are new announcements on Aeolus Pharmaceuticals, Inc.
Only registered members can use this feature.
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company. Its compound, AEOL 10150, is entering human clinical trials in oncology. AEOL 10150 had been tested in two Phase-I clinical trials.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.